Leslie V Norwalk

Director

Leslie V Norwalk (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $946K of NBIX (6,190 sh across 2 lots, as filed), executed Dec 15 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.5M

shares × price, as filed

Last traded

Jul 28

Filed Jul 30

Median ADV $194.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

NBIX Neurocrine Biosciences, Inc. NBIX · 0 buys · 4 sells 4 filings GMED

Globus Medical, Inc. GMED · 0 buys · 2 sells 2 filings

Recent filings

NBIXSALE Neurocrine Biosciences, Inc. View filing → $228K
1,250 sh × $182.01
Exec Jul 28
Filed Jul 30 · 5:29 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $210K
1,250 sh × $168.06
Exec Jun 4
Filed Jun 8 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $591K
3,810 sh × $155.01
Exec May 12
Filed May 14 · 5:30 PM ET GMEDSALE Globus Medical, Inc. View filing → $202K
2,000 sh × $101.10
Exec Jan 8
Filed Jan 12 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $946K
6,190 sh across 2 lots
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET GMEDSALE Globus Medical, Inc. View filing → $355K
4,000 sh × $88.85
Exec Dec 12 2025
Filed Dec 16 2025 · 5:30 PM ET